Recruiting PHASE3 INTERVENTIONAL 2-arm NCT05633576

Steroid Eye Drops in Chronic Central Serous Chorioretinopathy (PICS)

Steroid Eye Drops Versus Placebo Eye Drops in Chronic Central Serous Chorioretinopathy Trial (PICS Trial)

Sponsor: Oogziekenhuis Rotterdam

Conditions Chronic Central Serous Chorioretinopathy

Updated 5 times since 2022 Last updated: Apr 10, 2024 Started: Feb 19, 2023 Primary completion: Jun 19, 2025 Completion: Jul 19, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05633576, this PHASE3 trial focuses on Chronic Central Serous Chorioretinopathy and remains actively recruiting participants. Sponsored by Oogziekenhuis Rotterdam, it has been updated 5 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Recruiting PHASE3
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE3
May 2024 — Jul 2024 [monthly]

Recruiting PHASE3
Apr 2023 — May 2024 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Dec 2022 — Apr 2023 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oogziekenhuis Rotterdam
Radboud University Medical Center

Data source: Radboud University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nijmegen, Netherlands
• Rotterdam, Netherlands